ArticleEuropean urology2016

Urine TMPRSS2:ERG Plus PCA3 for Individualized Prostate Cancer Risk Assessment.

Scott A Tomlins et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.